Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Repeated S-ketamine infusions in therapy resistant depression: a case series.

Literature DB >> 23893490

Repeated S-ketamine infusions in therapy resistant depression: a case series.

Felix Segmiller¹, Tobias Rüther, Andrea Linhardt, Frank Padberg, Michael Berger, Oliver Pogarell, Hans-Jürgen Möller, Christina Kohler, Cornelius Schüle.

Abstract

Entities: Chemical Disease

Keywords: analgesiology/pain management (ANA); clinical trials (CTR); pharmacology (PHA); psychiatry (PSY); psychopharmacology (PSP)

Mesh：

Substances：

Year: 2013 PMID： 23893490 DOI： 10.1002/jcph.122

Source DB: PubMed Journal: J Clin Pharmacol ISSN： 0091-2700 Impact factor: 3.126

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

Review 1. Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.

Authors: Chadi G Abdallah; Lynnette A Averill; John H Krystal
Journal: Ann N Y Acad Sci Date: 2015-02-27 Impact factor: 5.691

Review 2. Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Authors: Gerard Sanacora; Alan F Schatzberg
Journal: Neuropsychopharmacology Date: 2014-09-26 Impact factor: 7.853

Review 3. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors: Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal: Pharmacol Rev Date: 2018-07 Impact factor: 25.468

Review 4. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.

Authors: Sidney H Kennedy; Raymond W Lam; Roger S McIntyre; S Valérie Tourjman; Venkat Bhat; Pierre Blier; Mehrul Hasnain; Fabrice Jollant; Anthony J Levitt; Glenda M MacQueen; Shane J McInerney; Diane McIntosh; Roumen V Milev; Daniel J Müller; Sagar V Parikh; Norma L Pearson; Arun V Ravindran; Rudolf Uher
Journal: Can J Psychiatry Date: 2016-08-02 Impact factor: 4.356

Repeated S-ketamine infusions in therapy resistant depression: a case series.

Review 1. Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.

Review 2. Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?

Review 3. Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Review 4. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.

Review 5. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.

Review 6. Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant.

7. Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders.

Review 8. The promise of ketamine for treatment-resistant depression: current evidence and future directions.

Review 9. Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.

Review 10. Role of Ketamine in the Treatment of Psychiatric Disorders.